POSACONAZOLE DELAYED-RELEASE

POSACONAZOLE DELAYED-RELEASE was reported 11286 times

POSACONAZOLE DELAYED-RELEASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 11 0.7857
1 PROTOTHECOSIS 34 0.3617
2 PSEUDOALDOSTERONISM 64 0.3232
3 MICROSPORUM INFECTION 8 0.2500
4 LEFT ATRIAL HYPERTROPHY 11 0.2200
5 DEMODICIDOSIS 19 0.2065
6 ACANTHAMOEBA KERATITIS 7 0.1892
7 FUSARIUM INFECTION 105 0.1500
8 TERTIARY ADRENAL INSUFFICIENCY 8 0.1481
9 MICROSPORIDIA INFECTION 50 0.1425
10 GEOTRICHUM INFECTION 29 0.1374
11 ADENOVIRUS REACTIVATION 19 0.1319
12 CHIMERISM 11 0.1236
13 ACANTHAMOEBA INFECTION 23 0.1223
14 APPARENT MINERALOCORTICOID EXCESS 7 0.1207
15 CEREBRAL VENTRICLE COLLAPSE 9 0.1200
16 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 7 0.1129
17 SCEDOSPORIUM INFECTION 79 0.1119
18 ENCEPHALITIS FUNGAL 10 0.1111
19 DISSEMINATED TOXOPLASMOSIS 13 0.1083
20 CORTICAL VISUAL IMPAIRMENT 6 0.1034
21 BRONCHIOLITIS OBLITERANS SYNDROME 18 0.1029
22 ALLOGENIC STEM CELL TRANSPLANTATION 16 0.1013
23 CORYNEBACTERIUM BACTERAEMIA 8 0.0941
24 BK POLYOMAVIRUS TEST POSITIVE 9 0.0938
25 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 21 0.0905
26 OVERGROWTH FUNGAL 9 0.0874
27 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 14 0.0809
28 BORDETELLA INFECTION 7 0.0778
29 DIFFERENTIATION SYNDROME 57 0.0777
30 EYE INFECTION FUNGAL 28 0.0724
31 DISSEMINATED COCCIDIOIDOMYCOSIS 10 0.0709
32 PULMONARY MUCORMYCOSIS 37 0.0701
33 ACUTE MYELOID LEUKAEMIA REFRACTORY 12 0.0698
34 ADENOVIRAL HEPATITIS 16 0.0681
35 MUCORMYCOSIS 171 0.0657
36 LIP SQUAMOUS CELL CARCINOMA 11 0.0655
37 MYCETOMA MYCOTIC 9 0.0647
38 PHAEOHYPHOMYCOSIS 31 0.0647
39 ACUTE MYELOID LEUKAEMIA RECURRENT 138 0.0642
40 MYCOTIC ENDOPHTHALMITIS 12 0.0635
41 RHINOCEREBRAL MUCORMYCOSIS 22 0.0634
42 HEPATOSPLENIC CANDIDIASIS 9 0.0612
43 QUADRANTANOPIA 8 0.0611
44 CUTANEOUS MUCORMYCOSIS 11 0.0598
45 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 12 0.0591
46 CEREBRAL ASPERGILLOSIS 35 0.0569
47 PRIMARY ADRENAL INSUFFICIENCY 17 0.0557
48 SYSTEMIC MYCOSIS 63 0.0539
49 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 10 0.0535
50 ELECTROCARDIOGRAM PR SHORTENED 11 0.0524
51 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 7 0.0515
52 CONGENITAL APLASIA 16 0.0514
53 ABSCESS FUNGAL 9 0.0514
54 CYSTITIS VIRAL 19 0.0496
55 OSTEOMYELITIS FUNGAL 8 0.0479
56 SKIN MACERATION 7 0.0458
57 DISSEMINATED MUCORMYCOSIS 17 0.0431
58 PNEUMONIA FUNGAL 166 0.0420
59 GASTROINTESTINAL MUCORMYCOSIS 7 0.0419
60 GRAFT VERSUS HOST DISEASE IN LIVER 30 0.0419
61 INTRAOCULAR PRESSURE TEST 10 0.0417
62 SEPTIC ENCEPHALOPATHY 7 0.0407
63 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 84 0.0394
64 HERPES SIMPLEX REACTIVATION 15 0.0394
65 LOWER RESPIRATORY TRACT INFECTION FUNGAL 15 0.0386
66 ECTHYMA 15 0.0374
67 LABELLED DRUG-DRUG INTERACTION ISSUE 54 0.0373
68 SYSTEMIC CANDIDA 93 0.0370
69 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
70 ZYGOMYCOSIS 17 0.0363
71 SEPTIC EMBOLUS 30 0.0361
72 GRAFT VERSUS HOST DISEASE IN LUNG 17 0.0356
73 CEREBRAL TOXOPLASMOSIS 33 0.0353
74 HERPES SIMPLEX TEST POSITIVE 7 0.0352
75 FUNGAEMIA 55 0.0349
76 ASPERGILLUS INFECTION 225 0.0342
77 GRAFT COMPLICATION 20 0.0341
78 KUSSMAUL RESPIRATION 7 0.0337
79 GRAFT VERSUS HOST DISEASE IN SKIN 74 0.0336
80 KLEBSIELLA BACTERAEMIA 31 0.0326
81 ASPERGILLUS TEST POSITIVE 10 0.0325
82 PULMONARY RESECTION 8 0.0323
83 UREAPLASMA INFECTION 13 0.0319
84 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0316
85 GRAFT VERSUS HOST DISEASE IN EYE 7 0.0303
86 CYTOMEGALOVIRUS INFECTION REACTIVATION 133 0.0301
87 SINUSITIS FUNGAL 24 0.0299
88 ENTEROBACTER BACTERAEMIA 9 0.0297
89 GRAFT VERSUS HOST DISEASE 212 0.0295
90 VENOUS HAEMORRHAGE 9 0.0290
91 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 41 0.0290
92 ENTEROCOCCAL BACTERAEMIA 30 0.0283
93 DERMATOPHYTOSIS 8 0.0282
94 VIRAL HAEMORRHAGIC CYSTITIS 20 0.0281
95 BRONCHOPULMONARY ASPERGILLOSIS 213 0.0274
96 CHOROIDAL EFFUSION 22 0.0274
97 TISSUE INFILTRATION 8 0.0271
98 CARDIAC VALVE VEGETATION 13 0.0267
99 FUNGAL ENDOCARDITIS 8 0.0266
100 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 19 0.0264
101 GROWTH FAILURE 9 0.0262
102 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 71 0.0257
103 CITROBACTER INFECTION 11 0.0256
104 NECROTISING RETINITIS 16 0.0250
105 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 9 0.0247
106 CHRONIC GRAFT VERSUS HOST DISEASE 87 0.0241
107 HYPERLEUKOCYTOSIS 21 0.0237
108 NEUTROPENIC INFECTION 22 0.0230
109 RETINAL ISCHAEMIA 14 0.0229
110 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 21 0.0227
111 PARAINFLUENZAE VIRUS INFECTION 33 0.0217
112 ENTEROBACTER SEPSIS 8 0.0216
113 STENOTROPHOMONAS INFECTION 29 0.0214
114 BK VIRUS INFECTION 72 0.0213
115 GLUCOCORTICOID DEFICIENCY 9 0.0213
116 RESPIRATORY TRACT INFECTION FUNGAL 11 0.0208
117 IDIOPATHIC PNEUMONIA SYNDROME 6 0.0201
118 BRAIN ABSCESS 51 0.0201
119 BRAIN COMPRESSION 8 0.0200
120 PSEUDOMONAL BACTERAEMIA 17 0.0199
121 KLEBSIELLA SEPSIS 22 0.0195
122 PULMONARY NOCARDIOSIS 16 0.0194
123 MYOPERICARDITIS 15 0.0192
124 POLYMYOSITIS 34 0.0192
125 PLATELET TRANSFUSION 24 0.0186
126 ENTEROCOCCAL INFECTION 89 0.0184
127 MYCOBACTERIUM ABSCESSUS INFECTION 13 0.0182
128 INFECTIVE ANEURYSM 9 0.0182
129 LUNG TRANSPLANT REJECTION 12 0.0182
130 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 60 0.0181
131 ANAEMIA MEGALOBLASTIC 8 0.0179
132 HAEMATOLOGICAL INFECTION 42 0.0172
133 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 8 0.0171
134 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 11 0.0168
135 CARDIOACTIVE DRUG LEVEL INCREASED 22 0.0167
136 PSEUDOMONAL SEPSIS 29 0.0165
137 STAPHYLOCOCCAL BACTERAEMIA 69 0.0159
138 HERPES SIMPLEX ENCEPHALITIS 7 0.0151
139 DISEASE RISK FACTOR 6 0.0149
140 ESCHERICHIA BACTERAEMIA 35 0.0149
141 MINIMAL RESIDUAL DISEASE 7 0.0145
142 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 19 0.0144
143 NEUTROPENIC COLITIS 29 0.0140
144 STEROID DIABETES 21 0.0140
145 FEBRILE NEUTROPENIA 917 0.0138
146 MEDIASTINITIS 8 0.0138
147 ACUTE MYELOID LEUKAEMIA 215 0.0138
148 CELLULITIS ORBITAL 8 0.0137
149 LEUKAEMIA RECURRENT 23 0.0136
150 PNEUMONIA KLEBSIELLA 25 0.0136
151 NOCARDIOSIS 34 0.0133
152 HUMAN POLYOMAVIRUS INFECTION 7 0.0132
153 HYPOFIBRINOGENAEMIA 13 0.0131
154 SOFT TISSUE INFECTION 24 0.0131
155 CORYNEBACTERIUM INFECTION 7 0.0131
156 PNEUMONIA PSEUDOMONAL 20 0.0130
157 CYTOMEGALOVIRUS ENTEROCOLITIS 10 0.0130
158 BLOOD IMMUNOGLOBULIN A INCREASED 7 0.0130
159 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0130
160 PSEUDOMONAS INFECTION 111 0.0129
161 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 10 0.0127
162 INTRACRANIAL MASS 12 0.0127
163 COCCIDIOIDOMYCOSIS 15 0.0126
164 ADENOVIRUS INFECTION 36 0.0124
165 ENTEROCOCCAL SEPSIS 10 0.0123
166 VENOOCCLUSIVE LIVER DISEASE 61 0.0123
167 CEREBRAL ARTERY EMBOLISM 15 0.0123
168 INFECTION REACTIVATION 14 0.0122
169 ENGRAFTMENT SYNDROME 7 0.0118
170 BACTERAEMIA 138 0.0116
171 METAPNEUMOVIRUS INFECTION 9 0.0115
172 CRYPTOSPORIDIOSIS INFECTION 6 0.0114
173 BLOOD IMMUNOGLOBULIN G DECREASED 28 0.0113
174 NEPHROGENIC DIABETES INSIPIDUS 13 0.0113
175 CYTOPENIA 138 0.0113
176 CANDIDA SEPSIS 10 0.0111
177 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 66 0.0111
178 FUNGAL SEPSIS 9 0.0108
179 EPSTEIN-BARR VIRAEMIA 12 0.0108
180 KLEBSIELLA INFECTION 54 0.0107
181 CENTRAL NERVOUS SYSTEM INFECTION 12 0.0105
182 SINUSITIS BACTERIAL 11 0.0104
183 CYTOMEGALOVIRUS VIRAEMIA 46 0.0103
184 HYPERBILIRUBINAEMIA 105 0.0101
185 ESCHERICHIA SEPSIS 29 0.0100
186 TUMOUR LYSIS SYNDROME 88 0.0100
187 ASPERGILLOSIS 13 0.0099
188 MUSCLE NECROSIS 9 0.0099
189 HYPOGONADISM 10 0.0099
190 BILIRUBIN CONJUGATED INCREASED 23 0.0098
191 ACUTE GRAFT VERSUS HOST DISEASE 45 0.0098
192 MYOSITIS 88 0.0098
193 BRAIN HERNIATION 29 0.0097
194 ARTHRITIS REACTIVE 6 0.0096
195 HEPATIC CYTOLYSIS 121 0.0095
196 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14 0.0093
197 PATHOGEN RESISTANCE 84 0.0092
198 BACTERIAL SEPSIS 30 0.0092
199 INFECTIOUS PLEURAL EFFUSION 14 0.0092
200 STAPHYLOCOCCAL SEPSIS 45 0.0091
201 PULMONARY MYCOSIS 7 0.0090
202 PULMONARY SEPSIS 13 0.0089
203 EXTREMITY NECROSIS 15 0.0086
204 LUNG CONSOLIDATION 24 0.0086
205 FEBRILE INFECTION 10 0.0085
206 SEPTIC SHOCK 368 0.0084
207 BONE MARROW TRANSPLANT 16 0.0084
208 ADRENAL SUPPRESSION 7 0.0083
209 STREPTOCOCCAL BACTERAEMIA 9 0.0083
210 BACTERIAL DISEASE CARRIER 6 0.0082
211 ENCEPHALITIS VIRAL 10 0.0082
212 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 21 0.0081
213 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 61 0.0081
214 TRANSPLANT 19 0.0080
215 LUNG OPACITY 21 0.0080
216 LONG QT SYNDROME 19 0.0079
217 JUGULAR VEIN THROMBOSIS 14 0.0079
218 ANGLE CLOSURE GLAUCOMA 20 0.0078
219 DEBRIDEMENT 6 0.0078
220 DRUG LEVEL BELOW THERAPEUTIC 43 0.0078
221 METHAEMOGLOBINAEMIA 18 0.0078
222 ACUTE LYMPHOCYTIC LEUKAEMIA 22 0.0078
223 ENTEROBACTER INFECTION 13 0.0077
224 HEPATIC NECROSIS 29 0.0077
225 ATYPICAL PNEUMONIA 23 0.0077
226 BLAST CELL COUNT INCREASED 8 0.0076
227 ILEUS PARALYTIC 34 0.0076
228 BONE MARROW TOXICITY 9 0.0076
229 OPTIC NEUROPATHY 16 0.0076
230 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 7 0.0076
231 HERPES SIMPLEX 49 0.0075
232 DEVICE RELATED INFECTION 116 0.0075
233 LEUKOENCEPHALOPATHY 28 0.0075
234 PLASMA CELL MYELOMA REFRACTORY 10 0.0075
235 CYSTITIS HAEMORRHAGIC 30 0.0074
236 CYTOKINE RELEASE SYNDROME 149 0.0074
237 DRUG RESISTANCE 190 0.0074
238 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
239 PNEUMONIA CYTOMEGALOVIRAL 14 0.0072
240 CROSS SENSITIVITY REACTION 7 0.0072
241 NEUTROPENIC SEPSIS 51 0.0071
242 DUODENAL PERFORATION 7 0.0071
243 MUCOSAL DISORDER 7 0.0070
244 HYPOGAMMAGLOBULINAEMIA 46 0.0070
245 CYTOMEGALOVIRUS INFECTION 116 0.0070
246 THROMBOTIC MICROANGIOPATHY 68 0.0070
247 NEPHROPATHY TOXIC 78 0.0069
248 DEMYELINATING POLYNEUROPATHY 7 0.0068
249 RHINOVIRUS INFECTION 26 0.0067
250 MULTIPLE ORGAN DYSFUNCTION SYNDROME 186 0.0066
251 VASCULAR PURPURA 9 0.0064
252 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 39 0.0064
253 ENTEROCOLITIS 37 0.0064
254 STEM CELL TRANSPLANT 16 0.0064
255 ACINETOBACTER INFECTION 7 0.0064
256 TORSADE DE POINTES 50 0.0064
257 HYPERAMMONAEMIC ENCEPHALOPATHY 11 0.0063
258 CANDIDA INFECTION 105 0.0062
259 FUNGAL SKIN INFECTION 25 0.0062
260 SKIN NECROSIS 32 0.0062
261 APLASTIC ANAEMIA 32 0.0061
262 OBLITERATIVE BRONCHIOLITIS 8 0.0061
263 DRUG LEVEL DECREASED 62 0.0061
264 FUNGAL INFECTION 202 0.0061
265 PACKED RED BLOOD CELL TRANSFUSION 8 0.0060
266 PAROTITIS 7 0.0060
267 GASTRIC DILATATION 10 0.0060
268 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 13 0.0059
269 PANCYTOPENIA 328 0.0059
270 GASTROINTESTINAL TOXICITY 28 0.0058
271 HUMAN HERPESVIRUS 6 INFECTION 11 0.0058
272 CAPILLARY LEAK SYNDROME 12 0.0058
273 GASTROINTESTINAL VIRAL INFECTION 6 0.0058
274 ENDOPHTHALMITIS 34 0.0057
275 CYTOMEGALOVIRUS COLITIS 13 0.0056
276 JC VIRUS INFECTION 9 0.0056
277 BONE MARROW DISORDER 17 0.0056
278 APLASIA 11 0.0056
279 EPSTEIN-BARR VIRUS INFECTION 35 0.0056
280 DISINHIBITION 9 0.0056
281 BONE NEOPLASM 6 0.0056
282 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 13 0.0055
283 MULTIPLE-DRUG RESISTANCE 17 0.0055
284 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
285 NEUROTOXICITY 94 0.0054
286 DRUG INTERACTION 838 0.0053
287 MYCOBACTERIAL INFECTION 9 0.0052
288 HEPATOTOXICITY 114 0.0051
289 CHOLESTASIS 97 0.0050
290 SERUM SICKNESS 14 0.0050
291 ESCHERICHIA TEST POSITIVE 6 0.0050
292 LUNG INFILTRATION 44 0.0050
293 NEUTROPENIA 675 0.0050
294 ORGAN FAILURE 20 0.0050
295 ACUTE LEUKAEMIA 8 0.0050
296 ATYPICAL MYCOBACTERIAL INFECTION 7 0.0049
297 BACTERIAL INFECTION 92 0.0049
298 DRUG LEVEL INCREASED 81 0.0049
299 HYPOMAGNESAEMIA 68 0.0049
300 BONE MARROW FAILURE 99 0.0049
301 HYPOPHOSPHATAEMIA 36 0.0049
302 TRANSPLANT REJECTION 39 0.0049
303 OTOTOXICITY 9 0.0049
304 ELECTROCARDIOGRAM QT PROLONGED 175 0.0049
305 VITRITIS 9 0.0049
306 HYPOKALAEMIA 224 0.0048
307 VARICELLA ZOSTER VIRUS INFECTION 10 0.0048
308 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 46 0.0048
309 ACUTE PULMONARY OEDEMA 27 0.0048
310 CEREBRAL HAEMATOMA 16 0.0048
311 NEUROLOGICAL DECOMPENSATION 11 0.0047
312 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
313 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 48 0.0047
314 STUPOR 15 0.0047
315 MIXED LIVER INJURY 14 0.0046
316 LYMPHOPENIA 65 0.0046
317 DRUG LEVEL ABOVE THERAPEUTIC 21 0.0046
318 CELL DEATH 9 0.0045
319 ESCHERICHIA INFECTION 37 0.0045
320 TRANSPLANT FAILURE 11 0.0045
321 ENCEPHALOPATHY 110 0.0045
322 DEVICE RELATED SEPSIS 9 0.0045
323 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0045
324 HISTOPLASMOSIS DISSEMINATED 7 0.0044
325 HOSPICE CARE 43 0.0043
326 LUNG ABSCESS 9 0.0043
327 ENDOCARDITIS 22 0.0043
328 ATRIOVENTRICULAR BLOCK SECOND DEGREE 13 0.0043
329 ORGANISING PNEUMONIA 21 0.0042
330 CATHETER SITE INFECTION 16 0.0042
331 MUCOSAL INFLAMMATION 110 0.0042
332 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37 0.0042
333 ACUTE RESPIRATORY DISTRESS SYNDROME 73 0.0041
334 CYTOMEGALOVIRUS CHORIORETINITIS 8 0.0041
335 PUPIL FIXED 7 0.0040
336 VASCULAR PSEUDOANEURYSM 7 0.0040
337 VENOOCCLUSIVE DISEASE 10 0.0040
338 CHRONIC GASTRITIS 9 0.0040
339 VASCULAR DEVICE INFECTION 18 0.0040
340 GASTROINTESTINAL OEDEMA 7 0.0040
341 ENTERITIS 25 0.0039
342 THROMBOCYTOPENIA 434 0.0039
343 PARONYCHIA 17 0.0039
344 RASH MACULO-PAPULAR 86 0.0039
345 TONGUE ULCERATION 13 0.0038
346 HEPATITIS TOXIC 10 0.0038
347 ORAL DISORDER 28 0.0038
348 BRAIN OEDEMA 48 0.0038
349 FEBRILE BONE MARROW APLASIA 16 0.0038
350 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
351 EXOPHTHALMOS 8 0.0037
352 STAPHYLOCOCCAL INFECTION 122 0.0037
353 NEUROLOGICAL SYMPTOM 21 0.0037
354 SERUM FERRITIN INCREASED 19 0.0036
355 POTENTIATING DRUG INTERACTION 12 0.0036
356 RENAL TUBULAR DISORDER 10 0.0036
357 VITAMIN B12 DECREASED 10 0.0035
358 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 8 0.0034
359 CUSHINGOID 11 0.0034
360 IMMUNOSUPPRESSION 30 0.0034
361 CLOSTRIDIUM DIFFICILE COLITIS 36 0.0034
362 LIVER ABSCESS 11 0.0034
363 LEUKAEMIA 32 0.0034
364 HYPOXIA 119 0.0034
365 PNEUMONIA BACTERIAL 31 0.0034
366 MYELOSUPPRESSION 121 0.0034
367 METABOLIC ENCEPHALOPATHY 10 0.0033
368 RENAL TUBULAR NECROSIS 32 0.0033
369 RESPIRATORY FAILURE 237 0.0032
370 TRANSFUSION 34 0.0032
371 RETINAL HAEMORRHAGE 23 0.0032
372 PERICARDIAL EFFUSION 74 0.0032
373 ELECTROLYTE IMBALANCE 37 0.0032
374 GASTROINTESTINAL ULCER 7 0.0032
375 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
376 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
377 PULMONARY HAEMORRHAGE 24 0.0031
378 MALABSORPTION 16 0.0031
379 GENE MUTATION 6 0.0030
380 PULMONARY ALVEOLAR HAEMORRHAGE 17 0.0030
381 BLOOD LACTATE DEHYDROGENASE INCREASED 48 0.0030
382 SCLERODERMA 11 0.0030
383 CYTOLYTIC HEPATITIS 10 0.0030
384 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
385 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
386 CHOLECYSTITIS ACUTE 17 0.0030
387 AREFLEXIA 8 0.0030
388 HEPATITIS CHOLESTATIC 18 0.0030
389 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0030
390 PAPULE 21 0.0030
391 AMYLASE INCREASED 11 0.0030
392 CARDIAC DYSFUNCTION 11 0.0030
393 BRONCHOPNEUMONIA 10 0.0029
394 DIASTOLIC DYSFUNCTION 9 0.0029
395 AGRANULOCYTOSIS 54 0.0029
396 BLOOD CREATININE ABNORMAL 10 0.0029
397 ENCEPHALITIS 20 0.0029
398 BLOOD BILIRUBIN INCREASED 77 0.0028
399 HEPATOMEGALY 28 0.0028
400 IRIDOCYCLITIS 9 0.0028
401 HYPERVOLAEMIA 14 0.0028
402 LUNG TRANSPLANT 10 0.0028
403 HYPERAMMONAEMIA 14 0.0028
404 SEPSIS 310 0.0028
405 MULTI-ORGAN FAILURE 48 0.0028
406 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
407 HAEMODYNAMIC INSTABILITY 21 0.0028
408 OLIGURIA 17 0.0027
409 BLOOD PHOSPHORUS DECREASED 10 0.0027
410 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
411 CARDIAC FAILURE ACUTE 18 0.0027
412 HYPOALBUMINAEMIA 21 0.0027
413 ACTINIC KERATOSIS 7 0.0027
414 NECROSIS 15 0.0027
415 CHOLESTATIC LIVER INJURY 6 0.0027
416 PERIPHERAL VENOUS DISEASE 11 0.0027
417 SINUS BRADYCARDIA 26 0.0027
418 PULMONARY MASS 40 0.0027
419 TRANSAMINASES INCREASED 59 0.0027
420 SQUAMOUS CELL CARCINOMA OF SKIN 16 0.0026
421 BLOOD POTASSIUM ABNORMAL 7 0.0026
422 ABDOMINAL TENDERNESS 13 0.0026
423 HYPERLACTACIDAEMIA 7 0.0026
424 ACUTE RESPIRATORY FAILURE 50 0.0026
425 ANAL ABSCESS 14 0.0026
426 SKIN INFECTION 29 0.0026
427 BLOOD ALKALINE PHOSPHATASE INCREASED 64 0.0026
428 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
429 HEPATIC FAILURE 77 0.0026
430 HEPATIC LESION 11 0.0025
431 PRODUCT USE IN UNAPPROVED INDICATION 629 0.0025
432 NEUTROPHIL COUNT DECREASED 103 0.0025
433 FAILURE TO THRIVE 13 0.0025
434 ENDOTRACHEAL INTUBATION 7 0.0025
435 LEUKOCYTOSIS 45 0.0025
436 NEUTROPHIL COUNT ABNORMAL 7 0.0025
437 CENTRAL NERVOUS SYSTEM LESION 34 0.0025
438 HYPOVENTILATION 8 0.0025
439 HYPERTRANSAMINASAEMIA 17 0.0024
440 DRUG-INDUCED LIVER INJURY 76 0.0024
441 DISEASE PROGRESSION 285 0.0024
442 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
443 BLOOD ALBUMIN DECREASED 19 0.0024
444 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
445 PROTEIN TOTAL DECREASED 9 0.0024
446 HYPERPYREXIA 10 0.0024
447 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 129 0.0023
448 PURULENT DISCHARGE 10 0.0023
449 HEPATOSPLENOMEGALY 6 0.0023
450 PROCTALGIA 15 0.0023
451 HEPATOCELLULAR INJURY 33 0.0023
452 APLASIA PURE RED CELL 8 0.0023
453 ACUTE KIDNEY INJURY 350 0.0023
454 COVID-19 PNEUMONIA 27 0.0023
455 CATATONIA 12 0.0023
456 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
457 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
458 PLEURAL EFFUSION 138 0.0023
459 JAUNDICE CHOLESTATIC 8 0.0023
460 MALNUTRITION 25 0.0022
461 VASCULITIS 26 0.0022
462 ADRENAL INSUFFICIENCY 27 0.0022
463 MYELODYSPLASTIC SYNDROME 32 0.0022
464 HYPERNATRAEMIA 11 0.0022
465 HEPATIC ENZYME ABNORMAL 11 0.0022
466 ILEUS 27 0.0022
467 TOXIC ENCEPHALOPATHY 11 0.0022
468 LARGE INTESTINE PERFORATION 15 0.0022
469 HALLUCINATIONS, MIXED 9 0.0021
470 CACHEXIA 11 0.0021
471 FULL BLOOD COUNT DECREASED 43 0.0021
472 PLATELET COUNT DECREASED 226 0.0021
473 ABSCESS LIMB 9 0.0021
474 CARDIAC TAMPONADE 10 0.0021
475 RESPIRATORY DISTRESS 58 0.0021
476 DUODENAL ULCER HAEMORRHAGE 6 0.0021
477 SHOCK HAEMORRHAGIC 17 0.0021
478 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
479 MENTAL STATUS CHANGES 56 0.0020
480 BLOOD CULTURE POSITIVE 6 0.0020
481 EJECTION FRACTION DECREASED 31 0.0020
482 SUSPECTED OFF LABEL USE 9 0.0020
483 EMBOLIC STROKE 7 0.0020
484 PLATELET COUNT ABNORMAL 12 0.0020
485 VENTRICULAR FIBRILLATION 22 0.0020
486 PYREXIA 679 0.0020
487 SUBDURAL HAEMATOMA 28 0.0020
488 IMMUNODEFICIENCY 29 0.0019
489 MONOCYTE COUNT INCREASED 7 0.0019
490 PERIORBITAL OEDEMA 10 0.0019
491 RED BLOOD CELL COUNT DECREASED 55 0.0019
492 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
493 FULL BLOOD COUNT ABNORMAL 20 0.0019
494 HEPATIC PAIN 8 0.0019
495 ATELECTASIS 18 0.0019
496 ANURIA 16 0.0019
497 GENERALISED OEDEMA 23 0.0019
498 BRAIN FOG 29 0.0018
499 TREATMENT FAILURE 153 0.0018
500 DECUBITUS ULCER 15 0.0018
501 PULMONARY FUNCTION TEST DECREASED 8 0.0018
502 ASPIRATION 20 0.0018
503 ORAL CANDIDIASIS 24 0.0018
504 INFLAMMATORY MARKER INCREASED 9 0.0018
505 CELLULITIS 91 0.0018
506 ASCITES 53 0.0018
507 LUNG INFECTION 28 0.0018
508 MENINGITIS 12 0.0018
509 HAEMOPTYSIS 50 0.0018
510 HAEMATOTOXICITY 17 0.0018
511 GASTROINTESTINAL INFECTION 16 0.0018
512 RESPIRATORY ACIDOSIS 7 0.0018
513 AZOTAEMIA 7 0.0018
514 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
515 IMMUNE THROMBOCYTOPENIA 8 0.0017
516 SKIN PAPILLOMA 7 0.0017
517 MYOPATHY 15 0.0017
518 HYDRONEPHROSIS 13 0.0017
519 BLOOD URIC ACID INCREASED 10 0.0017
520 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
521 SPLENOMEGALY 20 0.0017
522 ARTHRITIS BACTERIAL 7 0.0017
523 CARDIOMYOPATHY 25 0.0017
524 NODULE 22 0.0017
525 HAEMOLYSIS 13 0.0017
526 COAGULOPATHY 28 0.0017
527 SUBCUTANEOUS ABSCESS 8 0.0017
528 RENAL IMPAIRMENT 140 0.0017
529 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
530 HYPONATRAEMIA 92 0.0016
531 SQUAMOUS CELL CARCINOMA 15 0.0016
532 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
533 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
534 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
535 INFECTION 228 0.0016
536 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
537 SKIN LESION 43 0.0016
538 ABSCESS 25 0.0016
539 C-REACTIVE PROTEIN INCREASED 57 0.0016
540 HAEMATOCRIT DECREASED 31 0.0016
541 LEUKOPENIA 78 0.0016
542 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
543 HEPATIC FUNCTION ABNORMAL 58 0.0016
544 PNEUMONIA 501 0.0015
545 TACHYPNOEA 21 0.0015
546 CARDIOPULMONARY FAILURE 6 0.0015
547 HYPERTRIGLYCERIDAEMIA 9 0.0015
548 ORAL HERPES 30 0.0015
549 FOLLICULITIS 16 0.0015
550 HALLUCINATION, VISUAL 32 0.0015
551 CORONAVIRUS INFECTION 10 0.0015
552 CANDIDIASIS 6 0.0015
553 TOXIC SKIN ERUPTION 15 0.0015
554 HYPOPHAGIA 38 0.0015
555 MYOCARDITIS 17 0.0015
556 CHRONIC LYMPHOCYTIC LEUKAEMIA 7 0.0015
557 PURPURA 13 0.0015
558 HYDROCEPHALUS 8 0.0015
559 RESPIRATORY TRACT INFECTION 38 0.0015
560 VENTRICULAR TACHYCARDIA 24 0.0015
561 PHOTOSENSITIVITY REACTION 24 0.0015
562 COLITIS 55 0.0014
563 LIVER FUNCTION TEST ABNORMAL 42 0.0014
564 ACIDOSIS 11 0.0014
565 OFF LABEL USE 1260 0.0014
566 LIPASE INCREASED 11 0.0014
567 ALANINE AMINOTRANSFERASE INCREASED 88 0.0014
568 CEREBRAL HAEMORRHAGE 51 0.0014
569 THERAPY PARTIAL RESPONDER 22 0.0014
570 RENAL FAILURE 187 0.0014
571 HAEMOGLOBIN ABNORMAL 9 0.0014
572 LIVER INJURY 34 0.0014
573 DELIRIUM 48 0.0014
574 HYPOTHERMIA 14 0.0014
575 HYPOCALCAEMIA 26 0.0014
576 PETIT MAL EPILEPSY 7 0.0014
577 RESPIRATORY DISORDER 41 0.0014
578 HYPOVOLAEMIA 8 0.0014
579 BLOOD CREATININE INCREASED 89 0.0014
580 PNEUMONITIS 37 0.0014
581 PETECHIAE 14 0.0013
582 ODYNOPHAGIA 8 0.0013
583 HAEMOLYTIC ANAEMIA 12 0.0013
584 ANAEMIA 255 0.0013
585 ECCHYMOSIS 9 0.0013
586 ANAL FISTULA 7 0.0013
587 FLUID OVERLOAD 19 0.0013
588 ASPARTATE AMINOTRANSFERASE INCREASED 69 0.0013
589 BEHAVIOUR DISORDER 7 0.0013
590 ARTHRITIS INFECTIVE 6 0.0013
591 WHITE BLOOD CELL COUNT DECREASED 140 0.0013
592 CARDIAC ARREST 106 0.0013
593 GASTROINTESTINAL INFLAMMATION 10 0.0013
594 PULMONARY OEDEMA 57 0.0013
595 FACE OEDEMA 21 0.0012
596 ACUTE HEPATIC FAILURE 17 0.0012
597 DISEASE RECURRENCE 59 0.0012
598 RHINITIS 10 0.0012
599 MAJOR DEPRESSION 9 0.0012
600 HEPATITIS ACUTE 8 0.0012
601 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
602 HYPERCALCAEMIA 15 0.0012
603 STEVENS-JOHNSON SYNDROME 27 0.0012
604 LIVER FUNCTION TEST INCREASED 26 0.0012
605 HEPATIC ENZYME INCREASED 82 0.0012
606 PANCREATITIS ACUTE 27 0.0012
607 RHABDOMYOLYSIS 50 0.0012
608 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
609 HYPERGLYCAEMIA 43 0.0012
610 HYPERTHERMIA 9 0.0012
611 HEPATITIS 30 0.0012
612 NEPHROTIC SYNDROME 8 0.0012
613 SKIN HYPERPIGMENTATION 10 0.0012
614 BLOOD MAGNESIUM DECREASED 10 0.0012
615 METABOLIC ACIDOSIS 37 0.0012
616 VENTRICULAR EXTRASYSTOLES 12 0.0012
617 CONDITION AGGRAVATED 350 0.0011
618 HAEMOGLOBIN DECREASED 118 0.0011
619 MITRAL VALVE INCOMPETENCE 13 0.0011
620 LUNG DISORDER 56 0.0011
621 BLOOD UREA INCREASED 19 0.0011
622 TASTE DISORDER 23 0.0011
623 BRADYCARDIA 60 0.0011
624 DRUG ERUPTION 20 0.0011
625 ANAL FISSURE 6 0.0011
626 CIRCULATORY COLLAPSE 19 0.0011
627 TOXICITY TO VARIOUS AGENTS 188 0.0011
628 TACHYCARDIA 99 0.0011
629 OEDEMA 60 0.0011
630 HAEMORRHOIDS 21 0.0011
631 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
632 BLOOD COUNT ABNORMAL 16 0.0011
633 HYPERKALAEMIA 37 0.0011
634 SKIN MASS 7 0.0010
635 MOUTH ULCERATION 22 0.0010
636 BRONCHIECTASIS 7 0.0010
637 DIZZINESS POSTURAL 10 0.0010
638 THERAPY NON-RESPONDER 46 0.0010
639 VIRAL INFECTION 34 0.0010
640 CARDIAC FAILURE CONGESTIVE 82 0.0010
641 DRUG INEFFECTIVE 1343 0.0010
642 JOINT EFFUSION 7 0.0010
643 ATAXIA 12 0.0010
644 PNEUMOTHORAX 16 0.0010
645 TRICUSPID VALVE INCOMPETENCE 8 0.0010
646 GINGIVAL PAIN 8 0.0010
647 HEMIPARESIS 17 0.0010
648 POLYNEUROPATHY 12 0.0010
649 ANAL INCONTINENCE 9 0.0010
650 MELAENA 22 0.0010
651 BLOOD DISORDER 8 0.0010
652 STATUS EPILEPTICUS 11 0.0010
653 SCAB 11 0.0010
654 APPENDICITIS 9 0.0010
655 FAECES SOFT 7 0.0010
656 LYMPHOCYTE COUNT DECREASED 17 0.0010
657 PERICARDITIS 16 0.0010
658 GINGIVAL BLEEDING 13 0.0010
659 NEUROPATHY PERIPHERAL 90 0.0009
660 GENERAL PHYSICAL HEALTH DETERIORATION 109 0.0009
661 HAEMORRHAGE INTRACRANIAL 14 0.0009
662 CHOLECYSTITIS 11 0.0009
663 RENAL DISORDER 43 0.0009
664 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
665 TROPONIN INCREASED 7 0.0009
666 HALLUCINATION 69 0.0009
667 URINE OUTPUT DECREASED 8 0.0009
668 ATRIAL FIBRILLATION 89 0.0009
669 ATRIOVENTRICULAR BLOCK 7 0.0009
670 NO THERAPEUTIC RESPONSE 11 0.0009
671 HAEMORRHAGE 94 0.0009
672 SMALL INTESTINAL OBSTRUCTION 11 0.0009
673 INTESTINAL PERFORATION 10 0.0009
674 HYPOTENSION 177 0.0009
675 DRUG INTOLERANCE 85 0.0009
676 MYOCARDIAL ISCHAEMIA 10 0.0009
677 INTERNAL HAEMORRHAGE 10 0.0009
678 MUSCULAR WEAKNESS 99 0.0009
679 NEOPLASM 10 0.0009
680 MUSCLE ATROPHY 11 0.0009
681 BLOOD POTASSIUM DECREASED 26 0.0009
682 PRODUCT USE ISSUE 162 0.0009
683 ORTHOSTATIC HYPOTENSION 15 0.0009
684 HEPATIC ENCEPHALOPATHY 8 0.0009
685 ABNORMAL FAECES 7 0.0009
686 HIATUS HERNIA 11 0.0008
687 LABORATORY TEST ABNORMAL 25 0.0008
688 CARDIOGENIC SHOCK 12 0.0008
689 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
690 LIVER DISORDER 37 0.0008
691 OSTEOMYELITIS 15 0.0008
692 APHASIA 25 0.0008
693 RENAL INJURY 24 0.0008
694 PHARYNGITIS 10 0.0008
695 EYELID PTOSIS 8 0.0008
696 SUBARACHNOID HAEMORRHAGE 8 0.0008
697 ISCHAEMIC STROKE 14 0.0008
698 BODY TEMPERATURE INCREASED 16 0.0008
699 SHOCK 18 0.0008
700 SINUS TACHYCARDIA 11 0.0008
701 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
702 LACTIC ACIDOSIS 25 0.0008
703 COVID-19 135 0.0008
704 HAEMATURIA 26 0.0008
705 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
706 BLOOD PRESSURE ABNORMAL 15 0.0008
707 CHILLS 88 0.0007
708 NEOPLASM PROGRESSION 26 0.0007
709 GASTRIC ULCER 14 0.0007
710 PRODUCT PRESCRIBING ISSUE 16 0.0007
711 OESOPHAGITIS 8 0.0007
712 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
713 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
714 CYSTITIS 23 0.0007
715 URINARY TRACT INFECTION 123 0.0007
716 BLOOD CALCIUM DECREASED 8 0.0007
717 JAUNDICE 19 0.0007
718 NERVOUS SYSTEM DISORDER 22 0.0007
719 LOCALISED INFECTION 17 0.0007
720 BRAIN INJURY 7 0.0007
721 HEPATIC STEATOSIS 13 0.0007
722 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
723 SINUSITIS 71 0.0007
724 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
725 EYELID OEDEMA 8 0.0007
726 DEATH 592 0.0007
727 TYPE 2 DIABETES MELLITUS 23 0.0007
728 MALIGNANT MELANOMA 9 0.0007
729 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
730 GASTROINTESTINAL DISORDER 59 0.0007
731 SKIN ULCER 17 0.0007
732 OSTEOPOROSIS 27 0.0007
733 COMA 31 0.0007
734 DECREASED APPETITE 151 0.0006
735 OEDEMA PERIPHERAL 79 0.0006
736 CARDIAC FAILURE 52 0.0006
737 PULMONARY THROMBOSIS 7 0.0006
738 EPISTAXIS 48 0.0006
739 DRY EYE 32 0.0006
740 DIARRHOEA 403 0.0006
741 LYMPHADENOPATHY 22 0.0006
742 HAEMATOMA 16 0.0006
743 PRESYNCOPE 15 0.0006
744 PRODUCT AVAILABILITY ISSUE 14 0.0006
745 LETHARGY 35 0.0006
746 DISORIENTATION 24 0.0006
747 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
748 INTERSTITIAL LUNG DISEASE 29 0.0006
749 CONSTIPATION 130 0.0006
750 HYPERTENSION 126 0.0006
751 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
752 PULMONARY EMBOLISM 56 0.0006
753 DRUG TOXICITY 8 0.0006
754 OXYGEN SATURATION DECREASED 33 0.0006
755 UNRESPONSIVE TO STIMULI 15 0.0006
756 ASTHENIA 217 0.0006
757 PULMONARY HYPERTENSION 12 0.0006
758 ARRHYTHMIA 27 0.0006
759 SKIN DISORDER 19 0.0006
760 ABDOMINAL PAIN 132 0.0006
761 DIALYSIS 8 0.0006
762 PARALYSIS 8 0.0006
763 SKIN CANCER 12 0.0006
764 DRUG EFFECT INCOMPLETE 20 0.0006
765 CARDIO-RESPIRATORY ARREST 23 0.0005
766 SYNCOPE 55 0.0005
767 VISUAL IMPAIRMENT 68 0.0005
768 MYDRIASIS 7 0.0005
769 GENITAL HAEMORRHAGE 7 0.0005
770 SKIN HAEMORRHAGE 8 0.0005
771 ORAL PAIN 12 0.0005
772 SEIZURE 61 0.0005
773 DERMATITIS CONTACT 6 0.0005
774 PROTEINURIA 10 0.0005
775 PRODUCTIVE COUGH 25 0.0005
776 TENDONITIS 8 0.0005
777 PALLOR 14 0.0005
778 EOSINOPHILIA 9 0.0005
779 HAEMATEMESIS 13 0.0005
780 PANCREATITIS 27 0.0005
781 PERIPHERAL COLDNESS 7 0.0005
782 URINARY RETENTION 17 0.0005
783 DIVERTICULITIS 14 0.0005
784 SINUS DISORDER 10 0.0005
785 DYSPNOEA EXERTIONAL 19 0.0005
786 INFLAMMATION 26 0.0005
787 BLOOD TEST ABNORMAL 7 0.0005
788 BLINDNESS UNILATERAL 7 0.0005
789 RENAL FAILURE ACUTE 21 0.0005
790 STOMATITIS 30 0.0005
791 NEURALGIA 12 0.0005
792 CEREBRAL INFARCTION 12 0.0005
793 BLINDNESS 20 0.0005
794 BRONCHOSPASM 7 0.0005
795 CONFUSIONAL STATE 79 0.0005
796 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
797 DEHYDRATION 65 0.0005
798 CHROMATURIA 11 0.0005
799 VOMITING 229 0.0005
800 MYALGIA 82 0.0005
801 GASTROENTERITIS 7 0.0005
802 PHOTOPHOBIA 9 0.0005
803 BONE PAIN 28 0.0005
804 NAUSEA 371 0.0005
805 POST PROCEDURAL COMPLICATION 9 0.0005
806 COUGH 130 0.0005
807 HOSPITALISATION 71 0.0005
808 PLASMA CELL MYELOMA 18 0.0005
809 RASH ERYTHEMATOUS 22 0.0005
810 CATARACT 27 0.0005
811 MUSCULOSKELETAL CHEST PAIN 7 0.0005
812 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
813 AGEUSIA 11 0.0004
814 ACUTE MYOCARDIAL INFARCTION 13 0.0004
815 HALLUCINATION, AUDITORY 7 0.0004
816 RIB FRACTURE 9 0.0004
817 RESPIRATORY ARREST 12 0.0004
818 BLOOD POTASSIUM INCREASED 7 0.0004
819 DEEP VEIN THROMBOSIS 28 0.0004
820 INFLUENZA 48 0.0004
821 DERMATITIS 9 0.0004
822 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
823 CHOLELITHIASIS 14 0.0004
824 DYSPNOEA 240 0.0004
825 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
826 FATIGUE 329 0.0004
827 RETCHING 9 0.0004
828 ANGINA PECTORIS 12 0.0004
829 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
830 SKIN EXFOLIATION 35 0.0004
831 SOMNOLENCE 83 0.0004
832 APATHY 6 0.0004
833 THROMBOSIS 33 0.0004
834 MENORRHAGIA 8 0.0004
835 COGNITIVE DISORDER 19 0.0004
836 NIGHT SWEATS 13 0.0004
837 TREATMENT NONCOMPLIANCE 22 0.0004
838 MUSCULOSKELETAL PAIN 21 0.0004
839 PNEUMONIA ASPIRATION 10 0.0004
840 TREMOR 66 0.0004
841 ALOPECIA 78 0.0004
842 THERAPEUTIC RESPONSE DECREASED 24 0.0004
843 EPILEPSY 12 0.0004
844 CHEST DISCOMFORT 40 0.0004
845 FEMUR FRACTURE 12 0.0004
846 ABDOMINAL DISTENSION 40 0.0004
847 DEAFNESS 10 0.0004
848 AGITATION 28 0.0004
849 MALIGNANT NEOPLASM PROGRESSION 39 0.0004
850 PRODUCT PRESCRIBING ERROR 9 0.0004
851 MOBILITY DECREASED 27 0.0004
852 BLOOD SODIUM DECREASED 7 0.0004
853 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
854 MUSCULOSKELETAL DISORDER 7 0.0004
855 CHEST PAIN 67 0.0004
856 EAR PAIN 7 0.0004
857 WEIGHT DECREASED 100 0.0004
858 CARDIOVASCULAR DISORDER 9 0.0004
859 CONTUSION 34 0.0004
860 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
861 FEEDING DISORDER 7 0.0003
862 RASH 150 0.0003
863 RASH MACULAR 12 0.0003
864 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
865 IMPAIRED HEALING 11 0.0003
866 HEADACHE 210 0.0003
867 GOUT 6 0.0003
868 CONVULSION 19 0.0003
869 RASH PRURITIC 18 0.0003
870 PERIPHERAL SWELLING 51 0.0003
871 LOSS OF CONSCIOUSNESS 42 0.0003
872 FAECES DISCOLOURED 7 0.0003
873 EYE SWELLING 12 0.0003
874 SWELLING FACE 21 0.0003
875 MENTAL DISORDER 14 0.0003
876 PRODUCT DISPENSING ERROR 7 0.0003
877 EYE PAIN 18 0.0003
878 HEAD INJURY 10 0.0003
879 GLAUCOMA 6 0.0003
880 DRY MOUTH 25 0.0003
881 DIPLOPIA 8 0.0003
882 DYSPHAGIA 29 0.0003
883 GASTRITIS 8 0.0003
884 BLISTER 17 0.0003
885 INFUSION RELATED REACTION 20 0.0003
886 DIABETES MELLITUS 23 0.0003
887 ERYTHEMA 62 0.0003
888 BACK PAIN 70 0.0003
889 VISUAL ACUITY REDUCED 10 0.0003
890 HERPES ZOSTER 17 0.0003
891 BLOOD PRESSURE FLUCTUATION 7 0.0003
892 VISION BLURRED 40 0.0003
893 UNEVALUABLE EVENT 22 0.0003
894 FALL 95 0.0003
895 PAIN IN JAW 8 0.0003
896 FLUID RETENTION 14 0.0003
897 OSTEONECROSIS 9 0.0003
898 HAEMATOCHEZIA 15 0.0003
899 ADVERSE EVENT 25 0.0003
900 PSYCHOTIC DISORDER 8 0.0003
901 URINARY INCONTINENCE 8 0.0003
902 ECZEMA 14 0.0003
903 ADVERSE DRUG REACTION 24 0.0003
904 SWELLING 25 0.0003
905 UNDERDOSE 19 0.0003
906 OROPHARYNGEAL PAIN 24 0.0003
907 ABDOMINAL DISCOMFORT 43 0.0003
908 PRODUCT DOSE OMISSION ISSUE 75 0.0003
909 ILLNESS 26 0.0003
910 GAIT DISTURBANCE 48 0.0003
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
912 ANGIOEDEMA 11 0.0002
913 DIZZINESS 124 0.0002
914 CARDIAC DISORDER 23 0.0002
915 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
916 DYSURIA 9 0.0002
917 EYE DISORDER 8 0.0002
918 BALANCE DISORDER 21 0.0002
919 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 49 0.0002
920 TINNITUS 11 0.0002
921 SKIN DISCOLOURATION 11 0.0002
922 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
923 ANAPHYLACTIC REACTION 13 0.0002
924 RECTAL HAEMORRHAGE 10 0.0002
925 CORONARY ARTERY DISEASE 7 0.0002
926 BLOOD PRESSURE DECREASED 15 0.0002
927 DISTURBANCE IN ATTENTION 12 0.0002
928 FREQUENT BOWEL MOVEMENTS 6 0.0002
929 HEART RATE INCREASED 22 0.0002
930 WHEEZING 13 0.0002
931 RHINORRHOEA 14 0.0002
932 AMNESIA 14 0.0002
933 DYSARTHRIA 8 0.0002
934 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
935 HYPOGLYCAEMIA 10 0.0002
936 DYSPHONIA 12 0.0002
937 BRONCHITIS 15 0.0002
938 COLITIS ULCERATIVE 9 0.0002
939 WEIGHT INCREASED 45 0.0002
940 NEOPLASM MALIGNANT 13 0.0002
941 HYPOAESTHESIA 29 0.0002
942 BONE DENSITY DECREASED 6 0.0002
943 JOINT SWELLING 23 0.0002
944 PAIN IN EXTREMITY 56 0.0002
945 ABDOMINAL PAIN UPPER 39 0.0002
946 MALAISE 83 0.0002
947 DYSGEUSIA 14 0.0002
948 DRY SKIN 25 0.0002
949 HIP FRACTURE 6 0.0002
950 PARAESTHESIA 29 0.0002
951 PAIN 113 0.0002
952 ARTHRALGIA 76 0.0002
953 EYE PRURITUS 6 0.0002
954 FLATULENCE 10 0.0002
955 INCORRECT DOSE ADMINISTERED 40 0.0002
956 PRURITUS 67 0.0002
957 DYSPEPSIA 17 0.0002
958 ACNE 13 0.0002
959 MUSCULOSKELETAL STIFFNESS 15 0.0002
960 CHRONIC KIDNEY DISEASE 13 0.0002
961 MUSCLE SPASMS 31 0.0002
962 THERAPY INTERRUPTED 12 0.0002
963 POLLAKIURIA 7 0.0002
964 OVERDOSE 36 0.0002
965 ILL-DEFINED DISORDER 10 0.0002
966 VERTIGO 10 0.0002
967 HYPOACUSIS 7 0.0002
968 NECK PAIN 9 0.0002
969 INSOMNIA 42 0.0002
970 FLUSHING 16 0.0002
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
972 MEMORY IMPAIRMENT 21 0.0002
973 DEPRESSED MOOD 8 0.0002
974 ANXIETY 42 0.0001
975 SUICIDAL IDEATION 13 0.0001
976 SLEEP DISORDER 10 0.0001
977 BLOOD PRESSURE INCREASED 21 0.0001
978 INTENTIONAL PRODUCT MISUSE 12 0.0001
979 PALPITATIONS 16 0.0001
980 BLOOD GLUCOSE INCREASED 25 0.0001
981 MYOCARDIAL INFARCTION 23 0.0001
982 DISCOMFORT 8 0.0001
983 ARTHROPATHY 7 0.0001
984 INFLUENZA LIKE ILLNESS 10 0.0001
985 NASOPHARYNGITIS 22 0.0001
986 HYPERSENSITIVITY 22 0.0001
987 ASTHMA 13 0.0001
988 FEELING HOT 7 0.0001
989 URTICARIA 17 0.0001
990 CEREBROVASCULAR ACCIDENT 16 0.0001
991 FEELING ABNORMAL 20 0.0001
992 NO ADVERSE EVENT 15 0.0001
993 HYPERHIDROSIS 10 0.0001
994 ARTHRITIS 6 0.0001
995 DEPRESSION 16 0.0001